Previously undisclosed pre-clinical data showing how a new flu vaccine has the potential to protect against all strains of influenza, including pandemic and annual, was presented by PepTcell, at the 2007 Options for the Control of Influenza VI (Options) Conference, in Toronto, Canada.
Fifteen top international specialists in this field will gather from 25-27 June for a conference entitled, ?Inflammation and Chronic Disease?, part of the ?Barcelona BioMed? conference series organised by the Institute for Research in Biomedicine (IRB Barcelona) and the Fundaci?n BBVA.
A simple video-based awareness programme significantly improved hand washing among family members visiting sick children in a Paediatric Intensive Care Unit, according to research in the June issue of the UK-based Journal of Clinical Nursing.
In the study, ?Simple Models of Influenza Progression Within a Heterogeneous Population,? Dr. Richard C. Larson, a former president of INFORMS and a professor at MIT, discusses the importance of forecasting and ultimately limiting the spread of disease while taking into account the different infection rates among those who might contract the disease.
A comparison of three parasite species that cause Leishmaniasis has identified a small number of genes, many new to biology, that will provide a framework to target the search for new treatments. Leishmaniasis is a devastating disease that affects about two million people each year and threatens one-fifth of the world’s population and new treatments are desperately needed.
A NYC based anesthesiologist seemed to have passed on the hepatitis C infection to his patients. US Health Department is investigating a cluster of 3 new hepatitis C infections in people who received intravenous (IV) anesthesia from the same NYC-based anesthesiologist in August 2006.
Results of the Option (TOcilizumab Pivotal Trial in Methotrexate Inadequate respONders) trial, the first multinational Phase III study outside of Japan, showed that patients treated with Actemra (either 4mg/kg or 8mg/kg) plus methotrexate achieved a significant and clinically important improvement in the signs and symptoms of moderate to severe rheumatoid arthritis (RA) compared to patients treated with placebo and methotrexate, a current standard of care.
A study conducted in a large sample of postmenopausal women by University at Buffalo epidemiologists has provided new information on the prevalence of certain gum-disease-causing oral bacteria in this population and the association of the bacteria with oral bone loss.
Reported cases of Lyme disease have more than doubled since 1991, when Lyme became a nationally notifiable disease, according to a report by the Centers for Disease Control and Prevention (CDC). The report also said 93 percent of reported cases were concentrated in 10 states.
In a study appearing online on June 14 in advance of publication in the July print issue of the Journal of Clinical Investigation, researchers at Charit?-Universit?tsmedizin Berlin report that the molecule known as TRAIL can limit excessive immune responses in bacterial meningitis, and as such may be of use to control inflammation of the spinal cord and brain, which causes brain cell death in this life-threatening disease.